Core Scientific (CORZ) Change in Account Payables (2021 - 2026)

Core Scientific has disclosed Change in Account Payables across 6 years of filings, most recently posting -$41.5 million for Q2 2026.

• In Q2 2026, Change in Account Payables fell 128.05% year-over-year to -$41.5 million; the TTM figure through Jun 2026 stood at -$158.3 million (down 219.29% YoY), while the FY2025 annual figure was $10.8 million, up 187.86% from the prior year.
• Change in Account Payables came in at -$41.5 million for Q2 2026 at Core Scientific, down from $5.9 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $147.8 million in Q2 2025 to a low of -$151.1 million in Q3 2025.
• Average Change in Account Payables over 5 years is $6.0 million, with a median of $2.9 million recorded in 2024.
• The largest YoY upside for Change in Account Payables was 8571.4% in 2025 against a maximum downside of 94368.12% in 2025.
• Over 5 years, Change in Account Payables stood at $23.8 million in 2022, then soared by 262.56% to $86.1 million in 2023, then plunged by 100.73% to -$632000.0 in 2024, then surged by 4593.67% to $28.4 million in 2025, then slumped by 246.01% to -$41.5 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$41.5 million in Q2 2026, $5.9 million in Q1 2026, and $28.4 million in Q4 2025.